info@business-plan.co.za
Facebook
Business Plan Africa Investor-Ready Plans

Karoo Harvest Produce — Financial Projections

The following five-year income statement projection reflects the Company’s expected financial performance under base-case assumptions:

Karoo Harvest Produce (Pty) Ltd Business Plan › Financial Projections

Section 9 · Business Plan

Financial Projections

The following five-year income statement projection reflects the Company’s expected financial performance under base-case assumptions:

Year 5 Revenue
R47,000,000

With a stabilised EBITDA margin of 28–35% and the net margin expanding toward 24% by Year 5.

9.1 Key Assumptions

Assumption Value Basis
Cultivated area 100 hectares Farm plan
Average yield 72 tonnes/ha Northern Cape benchmark
Average selling price (Year 1) R4.17/kg blended Market agent data
Annual price escalation 5–7% CPI + demand growth
Annual cost inflation 5–7% CPI + input cost trends
Volume growth 5% p.a. to Year 3, then 3% Yield improvement + area expansion
Corporate tax rate 27% SA corporate income tax
Discount rate (WACC) 15% SA agribusiness risk premium
Depreciation Straight-line per SA GAAP See Section 7.3
Harvest loss 12% (Year 1), declining to 8% Industry standard

9.2 Revenue Projection

Figure
revenue_projection.png — visualised from the accompanying data.

9.3 Projected Profit & Loss Statement

The following five-year income statement projection reflects the Company’s expected financial performance under base-case assumptions:

INCOME STATEMENT (R’000) Year 1 Year 2 Year 3 Year 4 Year 5
Revenue 30,000 33,600 38,200 42,500 47,000
Fresh Produce Markets 15,000 15,500 16,500 17,000 18,000
Supermarket Contracts 9,000 10,500 12,500 14,500 16,000
Export Markets 3,500 4,500 5,500 7,000 8,500
Food Processors 2,500 3,100 3,700 4,000 4,500
Cost of Sales (18,500) (19,800) (21,500) (23,000) (24,500)
Seed & Seedlings (3,200) (3,360) (3,530) (3,700) (3,885)
Fertiliser & Chemicals (3,800) (3,990) (4,190) (4,400) (4,620)
Irrigation & Energy (2,500) (2,700) (2,920) (3,070) (3,224)
Labour (Direct) (4,300) (4,515) (4,741) (4,978) (5,227)
Packaging & Transport (4,000) (4,310) (4,660) (5,150) (5,544)
Harvest & Post-Harvest (700) (925) (1,459) (1,702) (2,000)
Gross Profit 11,500 13,800 16,700 19,500 22,500
Gross Margin % 38.3% 41.1% 43.7% 45.9% 47.9%
Operating Expenses (4,125) (4,290) (4,505) (4,730) (4,967)
Management & Admin (1,500) (1,575) (1,654) (1,737) (1,824)
Insurance (600) (630) (662) (695) (730)
Maintenance (1,000) (1,050) (1,103) (1,158) (1,216)
Professional Fees (400) (380) (360) (340) (320)
Marketing & Sales (350) (375) (426) (475) (527)
Miscellaneous (275) (280) (300) (325) (350)
EBITDA 7,375 9,510 12,195 14,770 17,533
EBITDA Margin % 24.6% 28.3% 31.9% 34.8% 37.3%
Depreciation (2,625) (2,625) (2,625) (2,625) (2,625)
OPERATING PROFIT (EBIT) 4,750 6,885 9,570 12,145 14,908
Interest Income 50 120 250 400 600
Interest Expense (250) (200) (150) (100) (50)
PROFIT BEFORE TAX 4,550 6,805 9,670 12,445 15,458
Taxation (27%) (1,229) (1,837) (2,611) (3,360) (4,174)
PROFIT AFTER TAX 3,322 4,968 7,059 9,085 11,284
Net Profit Margin % 11.1% 14.8% 18.5% 21.4% 24.0%

9.4 Profitability Analysis

Figure
profitability_trend.png — visualised from the accompanying data.

9.5 Projected Balance Sheet

The following balance sheet projection illustrates the Company’s expected financial position at each year-end:

BALANCE SHEET (R’000) Year 1 Year 2 Year 3 Year 4 Year 5
ASSETS
Non-Current Assets
Property, Plant & Equipment 38,000 37,375 36,750 36,125 35,500
Less: Accumulated Depreciation (2,625) (5,250) (7,875) (10,500) (13,125)
Net PP&E 35,375 32,125 28,875 25,625 22,375
Biological Assets 500 600 700 800 900
TOTAL Non-Current Assets 35,875 32,725 29,575 26,425 23,275
Current Assets
Inventory 3,200 3,500 3,800 4,100 4,400
Trade Receivables 4,500 5,040 5,730 6,375 7,050
Cash & Equivalents 6,800 11,500 18,200 27,500 39,000
Prepaid Expenses 400 420 440 460 480
TOTAL Current Assets 14,900 20,460 28,170 38,435 50,930
TOTAL ASSETS 50,775 53,185 57,745 64,860 74,205
EQUITY & LIABILITIES
Shareholders’ Equity
Share Capital 45,000 45,000 45,000 45,000 45,000
Retained Earnings 3,322 8,290 15,349 24,434 35,718
TOTAL EQUITY 48,322 53,290 60,349 69,434 80,718
Non-Current Liabilities
Long-Term Provisions 500 500 500 500 500
TOTAL Non-Current Liabilities 500 500 500 500 500
Current Liabilities
Trade Payables 1,200 1,320 1,452 1,597 1,757
Accrued Expenses 450 475 500 525 550
Tax Payable 303 600 944 1,204 1,480
Short-Term Provisions 0 0 0 0 0
TOTAL Current Liabilities 1,953 2,395 2,896 3,326 3,787
TOTAL EQUITY & LIABILITIES 50,775 56,185 63,745 73,260 85,005

Note: Balance sheet items rounded independently; minor rounding differences may occur.

9.6 Projected Cash Flow Statement

The projected cash flow statement demonstrates the Company’s ability to generate positive operating cash flows from Year 1 and achieve cumulative positive cash position by Year 4:

CASH FLOW STATEMENT (R’000) Year 1 Year 2 Year 3 Year 4 Year 5
OPERATING ACTIVITIES
Profit After Tax 3,322 4,968 7,059 9,085 11,284
Add: Depreciation 2,625 2,625 2,625 2,625 2,625
Changes in Working Capital (1,147) (513) (594) (626) (659)
Increase in Receivables (4,500) (540) (690) (645) (675)
Increase in Inventory (3,200) (300) (300) (300) (300)
Increase in Payables 1,200 120 132 145 157
Increase in Tax Payable 303 297 344 260 276
Other Working Capital 5,050 (90) (80) (86) (117)
NET OPERATING CASH FLOW 4,800 7,080 9,090 11,084 13,250
INVESTING ACTIVITIES
Capital Expenditure (38,000) (2,000) (2,000) (2,000) (2,000)
Biological Assets (500) (100) (100) (100) (100)
NET INVESTING CASH FLOW (38,500) (2,100) (2,100) (2,100) (2,100)
FINANCING ACTIVITIES
Equity Injection 45,000 0 0 0 0
Dividends Paid 0 0 0 0 0
NET FINANCING CASH FLOW 45,000 0 0 0 0
NET CASH FLOW 11,300 4,980 6,990 8,984 11,150
OPENING CASH BALANCE 0 11,300 16,280 23,270 32,254
CLOSING CASH BALANCE 11,300 16,280 23,270 32,254 43,404
Figure
cashflow_projection.png — visualised from the accompanying data.
Related sections

This document contains proprietary and confidential information. Distribution without written consent is prohibited.